Revolutionary AI Therapy for Comprehensive Brain Tumor Mapping to be Unveiled at SNIS Annual Meeting

Groundbreaking Advances in Neurointervention: Major Innovations at SNIS Annual Meeting

On July 20, 2026, the Society of NeuroInterventional Surgery (SNIS) will present significant advancements in the field of neurointervention during its 23rd Annual Meeting, hosted at the Seattle Convention Center. This year, clinicians and researchers will introduce a pioneering AI-guided technique designed to map the entirety of brain tumors, surpassing the limitations of traditional methods that concentrate on individual feeding arteries. The innovative approach aims to enhance targeted chemotherapy delivery by accurately identifying all vessels supplying the tumor, thereby improving patient outcomes.

The conference will encompass over 70 presentations, with a focus on various topics including stroke recovery, the impact of anesthesia during treatment, and racial disparities in cerebrovascular care. Attendees can expect to gain insights into the latest research and technologies that are poised to redefine standards of care across diverse medical settings.

In his discussion, SNIS President Dr. Guilherme Dabus emphasized, "The pace of innovation in neurointervention continues to accelerate. The work our members are presenting—covering tumors, stroke management, anesthesia, and health equity—is transformational. It goes beyond incremental changes and aims to reset the standards of care entirely. At the SNIS Annual Meeting, we foster discussions that ignite progress, ultimately saving lives."

Among the critical lectures, past SNIS President Dr. Joshua Hirsch will deliver the Grant Hieshima Luminary Lecture titled "Neurointervention at the Intersection of Innovation, Evidence, and Policy." Dr. Hirsch's extensive experience at Massachusetts General Hospital and Harvard Medical School, complemented by his upcoming role at the Keck School of Medicine of USC, positions him as a leader in advancing interdisciplinary neurointerventional programs. His impressive portfolio includes over 650 peer-reviewed publications, signifying his commitment to improving patient care through innovative solutions.

The meeting will also delve into themes of health equity, addressing racial disparities in endovascular thrombectomy, and analyzing various social determinants of health in stroke outcomes. Key abstracts set to be presented include:
- An examination of how racial disparities in thrombectomy widen based on stroke severity.
- A ten-year analysis of factors contributing to inequalities in outcomes following hemorrhagic stroke.
- Investigating the dual pathways leading to hemorrhagic stroke mortality in the U.S. Stroke Belt region.
- Research on how the use of general anesthesia impacts mortality rates in mechanical thrombectomy procedures.
- An exploration of AI’s capability to expand coverage for tumor treatment beyond single-pedicle methods.

For participants unable to attend in-person, the meeting offers a virtual option where attendees can stream sessions live, engage with presenters directly, and revisit recorded materials post-event. This inclusive format ensures that all registered attendees can access valuable content for months following the Annual Meeting.

For those interested in attending the conference, registration is available for both in-person and virtual options. Press credentials can be requested by contacting the SNIS directly. Additionally, interviews with key speakers like Dr. Dabus can be arranged to provide further insights into these significant developments.

The Society of NeuroInterventional Surgery remains dedicated to leading advancements in neurointerventional surgery through innovation and research. Their goal is to provide the highest quality of patient care while addressing critical challenges in diagnosing and treating conditions of the brain, spine, head, and neck. To explore more about their initiatives and updates, visit their official website or follow them on various social media platforms. This annual meeting promises to be a key event for those involved in neurointervention and sets the stage for future breakthroughs in patient care.